Doctor Barbara Pistilli

Dr Barbara Pistilli has been Head of the Breast Cancer Unit at Gustave Roussy since March 2021. Each year, the unit treats approximately 2,000 new patients and includes around 300 participants in clinical trials. Its core objective is to offer innovative and personalised strategies at every stage of the care pathway — from breast cancer prevention to post-treatment support, including the development of cutting-edge therapies.

The unit’s scientific strategy is built on a strong integration of clinical and translational research within large-scale programmes. Tumour biology plays a central role in guiding clinical development, while biological samples from patients drive translational research projects.

Dr Pistilli also leads OASIS, a major international project funded by the European Union’s Horizon Europe programme. The initiative aims to identify predictive biomarkers and companion diagnostics for antibody–drug conjugates (ADCs). She is also the principal investigator of numerous national and international phase II and III clinical trials in both early-stage and metastatic breast cancer.